[go: up one dir, main page]

BR0307317A - Tratamento de combinação para infartação miocardial aguda - Google Patents

Tratamento de combinação para infartação miocardial aguda

Info

Publication number
BR0307317A
BR0307317A BR0307317-3A BR0307317A BR0307317A BR 0307317 A BR0307317 A BR 0307317A BR 0307317 A BR0307317 A BR 0307317A BR 0307317 A BR0307317 A BR 0307317A
Authority
BR
Brazil
Prior art keywords
myocardial infarction
acute myocardial
combination treatment
combination
treatment
Prior art date
Application number
BR0307317-3A
Other languages
English (en)
Inventor
Pentti Pueder
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of BR0307317A publication Critical patent/BR0307317A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"TRATAMENTO DE COMBINAçãO PARA INFARTAçãO MIOCARDIAL AGUDA". Uma terapia de combinação para o tratamento de infartação miocardial aguda compreende administração de uma combinação de um agente trombolítico e levosimendan ou um seu sal farmaceuticamente aceitável a um paciente. A combinação reduz sinergisticamente mortalidade de pacientes com infartação miocardial aguda.
BR0307317-3A 2002-02-01 2003-01-31 Tratamento de combinação para infartação miocardial aguda BR0307317A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20020197A FI20020197A0 (fi) 2002-02-01 2002-02-01 Yhdistelmä akuutin myokardiilisen infarktin hoitoon
PCT/FI2003/000078 WO2003063870A1 (en) 2002-02-01 2003-01-31 A combination treatment for acute myocardial infarction

Publications (1)

Publication Number Publication Date
BR0307317A true BR0307317A (pt) 2005-01-04

Family

ID=8563019

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0307317-3A BR0307317A (pt) 2002-02-01 2003-01-31 Tratamento de combinação para infartação miocardial aguda

Country Status (19)

Country Link
US (1) US20050255096A1 (pt)
EP (1) EP1478362B1 (pt)
JP (1) JP2005516050A (pt)
CN (1) CN1291718C (pt)
AT (1) ATE306267T1 (pt)
AU (1) AU2003201980B2 (pt)
BR (1) BR0307317A (pt)
CA (1) CA2474430C (pt)
DE (1) DE60301862T2 (pt)
DK (1) DK1478362T3 (pt)
ES (1) ES2249707T3 (pt)
FI (1) FI20020197A0 (pt)
HK (1) HK1077215A1 (pt)
IL (1) IL163091A (pt)
MX (1) MXPA04007345A (pt)
NZ (1) NZ534221A (pt)
PL (1) PL212241B1 (pt)
WO (1) WO2003063870A1 (pt)
ZA (1) ZA200406085B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR298901A0 (en) 2001-02-07 2001-03-08 McComb Foundation, Inc., The Cell suspension preparation technique and device
FI20040674A0 (fi) 2004-05-12 2004-05-12 Orion Corp Menetelmä tromboembolisten sairauksien estoon
CA2596768A1 (en) * 2005-02-18 2006-08-24 Orion Corporation A method for treating heart failure
US9375440B2 (en) * 2006-11-03 2016-06-28 Medtronic, Inc. Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
US8324367B2 (en) 2006-11-03 2012-12-04 Medtronic, Inc. Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
WO2008082871A1 (en) * 2006-12-28 2008-07-10 Orion Corporation Formulations of levosimendan for parenteral administration
AU2013205148B2 (en) 2013-03-14 2014-10-30 AVITA Medical Americas, LLC Systems and methods for tissue processing and preparation of cell suspension therefrom
JP2023507626A (ja) 2019-12-16 2023-02-24 テナックス・セラピューティクス，インコーポレイテッド 駆出率が保たれた心不全を伴う肺高血圧症（ＰＨ－ＨＦ－ｐＥＦ）を治療するためのレボシメンダン
CN115518037A (zh) * 2022-10-14 2022-12-27 上药东英（江苏）药业有限公司 一种安全质量稳定的左西孟旦注射剂组合物及其制备方法
US20240209307A1 (en) 2022-12-27 2024-06-27 AVITA Medical Americas, LLC System for automated preparation of a regenerative epidermal suspension and related methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972990A (en) * 1992-04-10 1999-10-26 Brigham And Women's Hospital, Inc. Methods for reducing risk of repeat myocardial infarction and increasing survival in heart attack victims
GB2266841A (en) * 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
US5626601A (en) * 1995-10-27 1997-05-06 Gary Gershony Vascular sealing apparatus and method
US5510330A (en) * 1994-03-25 1996-04-23 Boehringer Mannheim Gmbh Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof.
US5463564A (en) * 1994-09-16 1995-10-31 3-Dimensional Pharmaceuticals, Inc. System and method of automatically generating chemical compounds with desired properties

Also Published As

Publication number Publication date
PL212241B1 (pl) 2012-08-31
ES2249707T3 (es) 2006-04-01
CN1291718C (zh) 2006-12-27
EP1478362B1 (en) 2005-10-12
IL163091A (en) 2012-06-28
WO2003063870A1 (en) 2003-08-07
ATE306267T1 (de) 2005-10-15
US20050255096A1 (en) 2005-11-17
FI20020197A0 (fi) 2002-02-01
PL371741A1 (en) 2005-06-27
MXPA04007345A (es) 2004-11-26
HK1077215A1 (en) 2006-02-10
ZA200406085B (en) 2005-10-06
NZ534221A (en) 2007-06-29
JP2005516050A (ja) 2005-06-02
AU2003201980B2 (en) 2006-12-07
EP1478362A1 (en) 2004-11-24
CN1625398A (zh) 2005-06-08
DK1478362T3 (da) 2005-11-14
DE60301862D1 (de) 2006-02-23
CA2474430C (en) 2010-09-28
CA2474430A1 (en) 2003-08-07
DE60301862T2 (de) 2006-07-20

Similar Documents

Publication Publication Date Title
BR0115162A (pt) Tratamentos antitumorais eficazes
NZ501069A (en) Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
CY1108629T1 (el) Συνδυασμος ετ 743 με 5 φθοριοουρακιλο προ-φαρμακα δια την θεραπευτικη αγωγη του καρκικου
CY1105818T1 (el) Χρησεις του et743 στην θepαπευτικη αγωγη του καρκινου
CY1109191T1 (el) Μια νεα χρηση της δεφεριπρονης
TW200616608A (en) Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients
BR0307317A (pt) Tratamento de combinação para infartação miocardial aguda
DK1781277T3 (da) Kombinationssammensætning, der omfatter Ibuprofen og Paracetamol
BR0016831A (pt) Composição terapêutica e lente de contato impregnada pela mesma
AU2002332488A8 (en) R-bambuterol, its preparation and therapeutic uses
EE200300328A (et) IL-18 inhibiitorite kasutamine südamehaiguse raviks ja/või ennetamiseks
PT1408977E (pt) Terapia de combinacao para o tratamento de falha cardiaca
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
TW200509909A (en) Use of organic compounds
SI1534296T1 (sl) Uporaba cilobradina ali njegovih farmacevtsko sprejemljivih soli za zdravljenje ali preprečevanje odpovedi srca
DE60111622D1 (de) Getrennte dosis therapien mit gefässschädigender aktivität
DK1239861T3 (da) Kombinationaf cyamemazin og et atypisk neuroleptikum
GR1004434B (el) Χρησηατουαdiclofenacαhααποδεκτωνααλατωνααυτουαγιαατηνααντιμετωπισηατωναεγκαυματων
DE60235965D1 (de) Kombination aus levosimendan und einer kalziumquelle zur behandlung von herzinsuffizienz
TW200509922A (en) Methods of therapeutic treatment using amounts of retinoid components
UA38447A (uk) Спосіб лікування безбольової ішемії міокарда у хворих на артеріальну гіпертензію

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.